Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Hip resurfacing arthroplasty complicated by mismatched implant components.

Calistri A, Campbell P, Van Der Straeten C, De Smet KA.

World J Orthop. 2017 Mar 18;8(3):286-289. doi: 10.5312/wjo.v8.i3.286. eCollection 2017 Mar 18.

2.

Current expert views on metal-on-metal hip resurfacing arthroplasty. Consensus of the 6th advanced Hip resurfacing course, Ghent, Belgium, May 2014.

Van Der Straeten C, De Smet KA.

Hip Int. 2016 Jan-Feb;26(1):1-7. doi: 10.5301/hipint.5000288. Epub 2015 Oct 6. Review.

PMID:
26449333
3.

Adverse clinical outcomes in a primary modular neck/stem system.

Calistri A, Van der Straeten C, De Smet KA.

J Arthroplasty. 2015 May;30(5):898. doi: 10.1016/j.arth.2014.11.038. Epub 2014 Dec 11. No abstract available.

PMID:
25540996
4.

The relationship between operative and radiographic acetabular component orientation: which factors influence resultant cup orientation?

Grammatopoulos G, Pandit HG, da Assunção R, McLardy-Smith P, De Smet KA, Gill HS, Murray DW.

Bone Joint J. 2014 Oct;96-B(10):1290-7. doi: 10.1302/0301-620X.96B10.34100.

PMID:
25274911
5.

Pelvic position and movement during hip replacement.

Grammatopoulos G, Pandit HG, da Assunção R, Taylor A, McLardy-Smith P, De Smet KA, Murray DW, Gill HS.

Bone Joint J. 2014 Jul;96-B(7):876-83. doi: 10.1302/0301-620X.96B7.32107.

PMID:
24986939
6.

The 2012 Otto Aufranc Award: The interpretation of metal ion levels in unilateral and bilateral hip resurfacing.

Van Der Straeten C, Grammatopoulos G, Gill HS, Calistri A, Campbell P, De Smet KA.

Clin Orthop Relat Res. 2013 Feb;471(2):377-85. doi: 10.1007/s11999-012-2526-x.

7.

Revisions of metal-on-metal hip resurfacing: lessons learned and improved outcome.

De Smet KA, Van Der Straeten C, Van Orsouw M, Doubi R, Backers K, Grammatopoulos G.

Orthop Clin North Am. 2011 Apr;42(2):259-69, ix. doi: 10.1016/j.ocl.2011.01.003.

PMID:
21435500
8.

Failure modes of 433 metal-on-metal hip implants: how, why, and wear.

Ebramzadeh E, Campbell PA, Takamura KM, Lu Z, Sangiorgio SN, Kalma JJ, De Smet KA, Amstutz HC.

Orthop Clin North Am. 2011 Apr;42(2):241-50, ix. doi: 10.1016/j.ocl.2011.01.001.

PMID:
21435498
9.

Adverse reaction to metal debris following hip resurfacing: the influence of component type, orientation and volumetric wear.

Langton DJ, Joyce TJ, Jameson SS, Lord J, Van Orsouw M, Holland JP, Nargol AV, De Smet KA.

J Bone Joint Surg Br. 2011 Feb;93(2):164-71. doi: 10.1302/0301-620X.93B2.25099. Erratum in: J Bone Joint Surg Br. 2011 Apr;93(4):566.

PMID:
21282753
10.

A modified posterior approach preserves femoral head oxgenation during hip resurfacing.

Steffen RT, De Smet KA, Murray DW, Gill HS.

J Arthroplasty. 2011 Apr;26(3):404-8. doi: 10.1016/j.arth.2009.12.018. Epub 2010 Mar 23.

PMID:
20334994
11.
12.

Does intraoperative cell salvage remove cobalt and chromium from reinfused blood?

Reijngoud LW, Pattyn C, De Haan R, De Somer F, Campbell PA, Gill HS, De Smet KA.

J Arthroplasty. 2009 Oct;24(7):1125-9. doi: 10.1016/j.arth.2008.06.019. Epub 2008 Sep 11.

PMID:
18789632
13.

Revision of metal-on-metal resurfacing arthroplasty of the hip: the influence of malpositioning of the components.

De Haan R, Campbell PA, Su EP, De Smet KA.

J Bone Joint Surg Br. 2008 Sep;90(9):1158-63. doi: 10.1302/0301-620X.90B9.19891.

PMID:
18757954
14.

Reduction of the potential for thermal damage during hip resurfacing.

Gill HS, Campbell PA, Murray DW, De Smet KA.

J Bone Joint Surg Br. 2007 Jan;89(1):16-20.

PMID:
17259409
15.

Belgium experience with metal-on-metal surface arthroplasty.

De Smet KA.

Orthop Clin North Am. 2005 Apr;36(2):203-13, ix.

PMID:
15833458
16.

Early resection of heterotopic ossification after total hip arthroplasty: A review of the literature.

De Smet KA, Pattyn C, Verdonck R.

Hip Int. 2002 Oct - Dec;12(4):383-387. doi: 10.5301/HIP.2008.1645.

PMID:
28124340
17.

Early results of primary Birmingham hip resurfacing using a hybrid metal-on-metal couple.

De Smet KA, Pattyn C, Verdonck R.

Hip Int. 2002 Apr-Jun;12(2):158-162. doi: 10.5301/HIP.2008.2140.

PMID:
28124361
18.

Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up.

Vandamme AM, Houyez F, Bànhegyi D, Clotet B, De Schrijver G, De Smet KA, Hall WW, Harrigan R, Hellmann N, Hertogs K, Holtzer C, Larder B, Pillay D, Race E, Schmit JC, Schuurman R, Schulse E, Sönnerborg A, Miller V.

Antivir Ther. 2001 Mar;6(1):21-39. Review.

PMID:
11417759
19.

Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.

Mestdagh M, Realini L, Fonteyne PA, Rossau R, Jannes G, Mijs W, DE Smet KA, Portaels F, Van den Eeckhout E.

Microb Drug Resist. 2000 Winter;6(4):283-7.

PMID:
11272256
20.

Three pathways for trehalose biosynthesis in mycobacteria.

De Smet KA, Weston A, Brown IN, Young DB, Robertson BD.

Microbiology. 2000 Jan;146 ( Pt 1):199-208.

PMID:
10658666
21.

Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis.

De Smet KA, Kempsell KE, Gallagher A, Duncan K, Young DB.

Microbiology. 1999 Nov;145 ( Pt 11):3177-84.

PMID:
10589726
22.

Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.

Mestdagh M, Fonteyne PA, Realini L, Rossau R, Jannes G, Mijs W, De Smet KA, Portaels F, Van den Eeckhout E.

Antimicrob Agents Chemother. 1999 Sep;43(9):2317-9.

23.
24.
25.

Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis.

Wilkinson RJ, Wilkinson KA, De Smet KA, Haslov K, Pasvol G, Singh M, Svarcova I, Ivanyi J.

Scand J Immunol. 1998 Oct;48(4):403-9.

26.

Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis.

De Rossi E, Blokpoel MC, Cantoni R, Branzoni M, Riccardi G, Young DB, De Smet KA, Ciferri O.

Antimicrob Agents Chemother. 1998 Aug;42(8):1931-7.

27.

Mycobacterium tuberculosis: beyond genome sequencing.

De Smet KA.

Trends Microbiol. 1997 Nov;5(11):429-31. No abstract available.

PMID:
9402696
28.

Duplication of genes encoding the immunodominant 38 kDa antigen in Mycobacterium intracellulare.

Thangaraj HS, Bull TJ, De Smet KA, Hill MK, Rouse DA, Moreno C, Ivanyi J.

FEMS Microbiol Lett. 1996 Nov 1;144(2-3):235-40.

PMID:
8900068
29.

Genetic and serovar typing of clinical isolates of the Mycobacterium avium-intracellulare complex.

De Smet KA, Hellyer TJ, Khan AW, Brown IN, Ivanyi J.

Tuber Lung Dis. 1996 Feb;77(1):71-6.

PMID:
8733418
31.

A versatile system for the production of recombinant chimeric peptides.

De Smet KA, Vordermeier HM, Ivanyi J.

J Immunol Methods. 1994 Dec 28;177(1-2):243-50.

PMID:
7529809
32.

Lipid synthesis in mycobacteria: characterization of the biotin carboxyl carrier protein genes from Mycobacterium leprae and M. tuberculosis.

Norman E, De Smet KA, Stoker NG, Ratledge C, Wheeler PR, Dale JW.

J Bacteriol. 1994 May;176(9):2525-31.

33.

Tropist3: a cosmid vector for simplified mapping of both G+C-rich and A+T-rich genomic DNA.

De Smet KA, Jamil S, Stoker NG.

Gene. 1993 Dec 22;136(1-2):215-9.

PMID:
8294005
34.

Sequence and immunological characterization of a serine-rich antigen from Mycobacterium leprae.

Vega-López F, Brooks LA, Dockrell HM, De Smet KA, Thompson JK, Hussain R, Stoker NG.

Infect Immun. 1993 May;61(5):2145-53.

Supplemental Content

Loading ...
Support Center